Literature DB >> 19820273

The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus.

Nikole M Scalera1, Sherif B Mossad.   

Abstract

Swine influenza was first described in the 1918 pandemic and made a resurgence in April 2009 in the form of a triple-reassortant influenza A virus, which is composed of a combination of human, swine, and Eurasian avian strains. As evidenced with previous influenza pandemics, young adults and children aged < 24 years are the population most affected. Definitive diagnosis has largely been limited by the inability of conventional influenza testing to distinguish among influenza A subtypes; however, the surge in pandemic cases clearly emerged at the end of the annual influenza season in the northern hemisphere. The pandemic variant influenza A (H1N1) strain is typically susceptible to oseltamivir and resistant to adamantanes, unlike the 2008 to 2009 seasonal influenza A (H1N1). However, 2 cases of oseltamivir-resistant pandemic-variant influenza A (H1N1) were reported in late August 2009. The full impact of the current pandemic is not yet clear, and further reassortment with the circulating seasonal influenza strains in the upcoming 2009 fall season could potentially lead to acquisition of widespread oseltamivir resistance. Vaccination will become paramount in importance for prevention and public health safety.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19820273     DOI: 10.3810/pgm.2009.09.2051

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  37 in total

1.  A Three-Dimensional Human Tissue-Engineered Lung Model to Study Influenza A Infection.

Authors:  Rudra Bhowmick; Tahereh Derakhshan; Yurong Liang; Jerry Ritchey; Lin Liu; Heather Gappa-Fahlenkamp
Journal:  Tissue Eng Part A       Date:  2018-06-29       Impact factor: 3.845

2.  High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity.

Authors:  Ching-Yao Su; Ting-Jen R Cheng; Meng-I Lin; Shi-Yun Wang; Wen-I Huang; Shao-Ying Lin-Chu; Yu-Hou Chen; Chung-Yi Wu; Michael M C Lai; Wei-Chieh Cheng; Ying-Ta Wu; Ming-Daw Tsai; Yih-Shyun E Cheng; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

3.  Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181.

Authors:  Gallen B Triana-Baltzer; Rebecca L Sanders; Maria Hedlund; Kellie A Jensen; Laura M Aschenbrenner; Jeffrey L Larson; Fang Fang
Journal:  J Antimicrob Chemother       Date:  2010-11-21       Impact factor: 5.790

Review 4.  Single enzyme nanoparticle, an effective tool for enzyme replacement therapy.

Authors:  Dong Hyun Kim; Han Sol Lee; Tae-Wan Kwon; Young-Min Han; Nae-Won Kang; Mee Yeon Lee; Dae-Duk Kim; Myeong Gyu Kim; Jae-Young Lee
Journal:  Arch Pharm Res       Date:  2020-01-27       Impact factor: 4.946

5.  Pandemic H1N1 influenza A infection and (atypical) HUS--more than just another trigger?

Authors:  Upton Allen; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2010-11-07       Impact factor: 3.714

Review 6.  [Anaphylactic reactions to vaccines : Chicken egg allergy and the influenza H1N1 vaccination].

Authors:  L Klimek; S Wicht-Langhammer; L von Bernus; C Thorn; D Cazan; O Pfaar; K Hörmann
Journal:  HNO       Date:  2017-10       Impact factor: 1.284

7.  Awareness, attitudes, and practices related to the swine influenza pandemic among the Saudi public.

Authors:  Hanan H Balkhy; Mostafa A Abolfotouh; Rawabi H Al-Hathlool; Mohammad A Al-Jumah
Journal:  BMC Infect Dis       Date:  2010-02-28       Impact factor: 3.090

8.  Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea.

Authors:  Jia-xin Ling; Fei Wei; Ning Li; Jin-lin Li; Liang-jun Chen; Yuan-yuan Liu; Fan Luo; Hai-rong Xiong; Wei Hou; Zhan-qiu Yang
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

9.  Preliminary study about sublingual administration of bacteria-expressed pandemic H1N1 influenza vaccine in miniature pigs.

Authors:  Hyekwon Kim; Jeong-Ki Kim; Hohyun Song; Jungah Choi; Byoungshik Shim; Bokyu Kang; Hyoungjoon Moon; Minjoo Yeom; Sang-Hyun Kim; Daesub Song; Manki Song
Journal:  J Microbiol       Date:  2014-07-30       Impact factor: 3.422

10.  Risk Factors for influenza A(H1N1)pdm09 among students, Beijing, China.

Authors:  Yang Zheng; Wei Duan; Peng Yang; Yi Zhang; Xiaoli Wang; Li Zhang; Surabhi S Liyanage; Quanyi Wang
Journal:  Emerg Infect Dis       Date:  2013-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.